Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MANGALAM DRUGS vs GLAND PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MANGALAM DRUGS GLAND PHARMA MANGALAM DRUGS/
GLAND PHARMA
 
P/E (TTM) x -8.6 46.1 - View Chart
P/BV x 1.0 3.8 25.3% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 MANGALAM DRUGS   GLAND PHARMA
EQUITY SHARE DATA
    MANGALAM DRUGS
Mar-23
GLAND PHARMA
Mar-23
MANGALAM DRUGS/
GLAND PHARMA
5-Yr Chart
Click to enlarge
High Rs1733,556 4.9%   
Low Rs951,130 8.4%   
Sales per share (Unadj.) Rs235.2214.5 109.6%  
Earnings per share (Unadj.) Rs0.847.5 1.7%  
Cash flow per share (Unadj.) Rs7.756.5 13.7%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs96.0484.3 19.8%  
Shares outstanding (eoy) m15.83164.30 9.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.610.9 5.2%   
Avg P/E ratio x166.849.3 338.4%  
P/CF ratio (eoy) x17.341.5 41.6%  
Price / Book Value ratio x1.44.8 28.8%  
Dividend payout %00-   
Avg Mkt Cap Rs m2,118385,002 0.6%   
No. of employees `000NANA-   
Total wages/salary Rs m3464,033 8.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m3,72335,245 10.6%  
Other income Rs m42,405 0.2%   
Total revenues Rs m3,72737,650 9.9%   
Gross profit Rs m2559,683 2.6%  
Depreciation Rs m1101,467 7.5%   
Interest Rs m12874 171.2%   
Profit before tax Rs m2210,546 0.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m92,735 0.3%   
Profit after tax Rs m137,810 0.2%  
Gross profit margin %6.927.5 25.0%  
Effective tax rate %42.625.9 164.3%   
Net profit margin %0.322.2 1.5%  
BALANCE SHEET DATA
Current assets Rs m2,06669,008 3.0%   
Current liabilities Rs m1,6547,291 22.7%   
Net working cap to sales %11.1175.1 6.3%  
Current ratio x1.29.5 13.2%  
Inventory Days Days113 8.8%  
Debtors Days Days45690 505.6%  
Net fixed assets Rs m1,53018,767 8.2%   
Share capital Rs m158165 96.1%   
"Free" reserves Rs m1,36179,406 1.7%   
Net worth Rs m1,52079,571 1.9%   
Long term debt Rs m18833 575.5%   
Total assets Rs m3,59687,775 4.1%  
Interest coverage x1.2142.6 0.8%   
Debt to equity ratio x0.10 30,133.9%  
Sales to assets ratio x1.00.4 257.8%   
Return on assets %3.99.0 43.4%  
Return on equity %0.89.8 8.5%  
Return on capital %8.813.3 65.7%  
Exports to sales %086.8 0.0%   
Imports to sales %25.70-   
Exports (fob) Rs mNA30,590 0.0%   
Imports (cif) Rs m958NA-   
Fx inflow Rs m1,07830,590 3.5%   
Fx outflow Rs m97817,819 5.5%   
Net fx Rs m10012,771 0.8%   
CASH FLOW
From Operations Rs m3953,640 10.9%  
From Investments Rs m-22212,082 -1.8%  
From Financial Activity Rs m-166149 -111.4%  
Net Cashflow Rs m715,901 0.0%  

Share Holding

Indian Promoters % 50.3 0.0 -  
Foreign collaborators % 0.0 57.9 -  
Indian inst/Mut Fund % 0.1 28.2 0.4%  
FIIs % 0.1 4.1 2.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 49.7 42.1 117.9%  
Shareholders   18,610 136,021 13.7%  
Pledged promoter(s) holding % 18.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MANGALAM DRUGS With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on MANGALAM DRUGS vs GLAND PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

MANGALAM DRUGS vs GLAND PHARMA Share Price Performance

Period MANGALAM DRUGS GLAND PHARMA S&P BSE HEALTHCARE
1-Day -1.17% 1.22% 1.18%
1-Month -23.18% 2.37% -0.75%
1-Year -7.12% 46.44% 61.82%
3-Year CAGR -3.92% -9.62% 18.16%
5-Year CAGR 10.44% 0.23% 19.79%

* Compound Annual Growth Rate

Here are more details on the MANGALAM DRUGS share price and the GLAND PHARMA share price.

Moving on to shareholding structures...

The promoters of MANGALAM DRUGS hold a 50.3% stake in the company. In case of GLAND PHARMA the stake stands at 57.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of MANGALAM DRUGS and the shareholding pattern of GLAND PHARMA.

Finally, a word on dividends...

In the most recent financial year, MANGALAM DRUGS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

GLAND PHARMA paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of MANGALAM DRUGS, and the dividend history of GLAND PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.